JP2013536419A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536419A5 JP2013536419A5 JP2013524450A JP2013524450A JP2013536419A5 JP 2013536419 A5 JP2013536419 A5 JP 2013536419A5 JP 2013524450 A JP2013524450 A JP 2013524450A JP 2013524450 A JP2013524450 A JP 2013524450A JP 2013536419 A5 JP2013536419 A5 JP 2013536419A5
- Authority
- JP
- Japan
- Prior art keywords
- tmab
- monoclonal antibody
- antibody
- alternative
- agg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 18
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 8
- 239000007790 solid phase Substances 0.000 claims 5
- 229960002685 biotin Drugs 0.000 claims 4
- 235000020958 biotin Nutrition 0.000 claims 4
- 239000011616 biotin Substances 0.000 claims 4
- 229960004641 rituximab Drugs 0.000 claims 4
- 206010061623 Adverse drug reaction Diseases 0.000 claims 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 claims 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 3
- 229960002964 adalimumab Drugs 0.000 claims 3
- 229960003115 certolizumab pegol Drugs 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 229960000598 infliximab Drugs 0.000 claims 3
- 238000010494 dissociation reaction Methods 0.000 claims 2
- 230000005593 dissociations Effects 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 108090001008 Avidin Proteins 0.000 claims 1
- 108010090804 Streptavidin Proteins 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229940126622 therapeutic monoclonal antibody Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10173408.5 | 2010-08-19 | ||
| EP10173408 | 2010-08-19 | ||
| PCT/EP2011/064178 WO2012022774A1 (en) | 2010-08-19 | 2011-08-17 | An assay for measurement of antibodies binding to a therapeutic monoclonal antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013536419A JP2013536419A (ja) | 2013-09-19 |
| JP2013536419A5 true JP2013536419A5 (enExample) | 2014-04-24 |
| JP5805190B2 JP5805190B2 (ja) | 2015-11-04 |
Family
ID=42727619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524450A Active JP5805190B2 (ja) | 2010-08-19 | 2011-08-17 | 療法用モノクローナル抗体に結合する抗体の測定のためのアッセイ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9081016B2 (enExample) |
| EP (1) | EP2606362B1 (enExample) |
| JP (1) | JP5805190B2 (enExample) |
| CN (1) | CN103109190B (enExample) |
| CA (1) | CA2802278A1 (enExample) |
| ES (1) | ES2555864T3 (enExample) |
| WO (1) | WO2012022774A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104614535B (zh) * | 2015-02-10 | 2017-11-28 | 深圳市新产业生物医学工程股份有限公司 | 甲状腺微粒体抗体检测试剂盒及其制备方法和应用 |
| EP3482199A1 (en) * | 2016-07-08 | 2019-05-15 | Atonomics A/S | A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples |
| CN106093413A (zh) * | 2016-07-18 | 2016-11-09 | 本·沙朗 | 一种抗英夫利西抗体elisa检测试剂盒和检测方法 |
| US11698367B2 (en) * | 2017-09-15 | 2023-07-11 | Beckman Coulter, Inc. | Flow based assays for therapeutics |
| WO2019191280A1 (en) * | 2018-03-27 | 2019-10-03 | Laboratory Corporation Of America Holdings | Sandwich elisa for identifying subjects who may benefit from treatment with therapeutic agents |
| JP7570421B2 (ja) * | 2020-01-02 | 2024-10-21 | エフ． ホフマン－ラ ロシュ アーゲー | Ａｄａ応答特定アッセイ |
| CN115552244A (zh) * | 2020-05-08 | 2022-12-30 | 豪夫迈·罗氏有限公司 | 用于高药物耐受性测试的高离子强度解离测定 |
| CN117590002B (zh) * | 2023-11-23 | 2024-10-22 | 上海领检科技有限公司 | 一种TNFα抗药抗体的检测方法及检测试剂盒 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1508132A (en) | 1974-05-20 | 1978-04-19 | Technicon Instr | Analysis of biological fluids |
| US5219730A (en) | 1982-09-28 | 1993-06-15 | New York University | Idiotype-anti-idiotype immunoassay |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4554088A (en) | 1983-05-12 | 1985-11-19 | Advanced Magnetics Inc. | Magnetic particles for use in separations |
| US4628037A (en) | 1983-05-12 | 1986-12-09 | Advanced Magnetics, Inc. | Binding assays employing magnetic particles |
| US4695393A (en) | 1983-05-12 | 1987-09-22 | Advanced Magnetics Inc. | Magnetic particles for use in separations |
| US4698302A (en) | 1983-05-12 | 1987-10-06 | Advanced Magnetics, Inc. | Enzymatic reactions using magnetic particles |
| US4828981A (en) | 1983-08-24 | 1989-05-09 | Synbiotics Corporation | Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents |
| EP0170302A1 (fr) | 1984-06-27 | 1986-02-05 | l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire | Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques |
| US5238808A (en) | 1984-10-31 | 1993-08-24 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| JPH0823558B2 (ja) | 1984-11-27 | 1996-03-06 | オ−ジエニクス リミテツド | 検定装置 |
| DE3689645D1 (de) | 1985-10-16 | 1994-03-24 | Fresenius Ag | Selektives Adsorbens zur Bindung von Immunkomplexen. |
| EP0243471A4 (en) | 1985-10-22 | 1989-07-11 | Cooper Lipotech Inc | SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM. |
| US6316607B1 (en) | 1986-04-30 | 2001-11-13 | Igen International, Inc. | Electrochemiluminescent assays |
| US4965392A (en) | 1987-03-26 | 1990-10-23 | Neorx Corporation | Chelating compounds for metal-radionuclide labeled proteins |
| US5935779A (en) | 1988-11-03 | 1999-08-10 | Igen International Inc. | Methods for improved particle electrochemiluminescence assay |
| GB8803000D0 (en) | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| KR0143993B1 (ko) | 1988-11-03 | 1998-07-15 | 리차아드 제이 매씨이 | 전기화학 발광성 분석 |
| US5068088A (en) | 1988-11-03 | 1991-11-26 | Igen, Inc. | Method and apparatus for conducting electrochemiluminescent measurements |
| WO1990006515A1 (en) | 1988-12-09 | 1990-06-14 | Centocor, Inc. | Anti-idiotopic immunometric assay |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5364930A (en) | 1990-10-16 | 1994-11-15 | Northwestern University | Synthetic C1q peptide fragments |
| WO1992009690A2 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with altered binding properties |
| IL100866A (en) | 1991-02-06 | 1995-10-31 | Igen Inc | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets |
| WO1993008472A1 (en) | 1991-10-15 | 1993-04-29 | Multilyte Limited | Binding assay employing labelled reagent |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| US5466416A (en) | 1993-05-14 | 1995-11-14 | Ghaed; Ali | Apparatus and methods for carrying out electrochemiluminescence test measurements |
| US6241963B1 (en) | 1995-10-19 | 2001-06-05 | The Trustees Of The University Of Pennsylvania | Dopamine and serotonin transporter ligands and imaging agents |
| DE19806989A1 (de) | 1998-02-19 | 1999-08-26 | Roche Diagnostics Gmbh | Erzeugung räumlich scharf begrenzter Festphasen für Bindungsassays |
| IT1315254B1 (it) | 1999-11-05 | 2003-02-03 | Diesse Diagnostica Senese Spa | Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc. |
| DE60025526T2 (de) | 1999-11-16 | 2006-08-24 | Genentech, Inc., South San Francisco | Elisa für vegf |
| US20050130246A1 (en) | 2003-10-27 | 2005-06-16 | Hossein Salimi-Moosavi | Detecting human anti-therapeutic antibodies |
| DE102004052729A1 (de) | 2004-10-30 | 2006-05-04 | Roche Diagnostics Gmbh | Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten |
| DK2645106T4 (da) | 2005-04-04 | 2024-12-02 | Biogen Ma Inc | Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel |
| MX2008012013A (es) | 2006-03-23 | 2008-10-03 | Novartis Ag | Tratamiento con anticuerpo antigeno de celulas neoplasicas. |
| KR20090094814A (ko) | 2006-10-10 | 2009-09-08 | 스퀴코어 | 암의 치료 및 진단을 위한 조성물 및 방법 |
| WO2009003082A2 (en) * | 2007-06-26 | 2008-12-31 | Vanderbilt University | Immunological compositions as cancer biomarkers and/or therapeutics |
-
2011
- 2011-08-17 EP EP11746230.9A patent/EP2606362B1/en active Active
- 2011-08-17 JP JP2013524450A patent/JP5805190B2/ja active Active
- 2011-08-17 ES ES11746230.9T patent/ES2555864T3/es active Active
- 2011-08-17 CA CA2802278A patent/CA2802278A1/en not_active Abandoned
- 2011-08-17 CN CN201180042537.9A patent/CN103109190B/zh active Active
- 2011-08-17 WO PCT/EP2011/064178 patent/WO2012022774A1/en not_active Ceased
-
2013
- 2013-02-13 US US13/766,130 patent/US9081016B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536419A5 (enExample) | ||
| JP7105970B1 (ja) | ＳＡＲＳ－ＣｏＶ－２の免疫測定方法及び免疫測定キット | |
| JP2018535404A5 (enExample) | ||
| RU2009116611A (ru) | Твердофазный иммуноферментный анализ (elisa) для фактора роста эндотелия сосудов (vegf) | |
| JP5586368B2 (ja) | 腫瘍マーカーとしてのｎ１，ｎ１２−ジアセチルスペルミン | |
| FI3356827T3 (fi) | GDF-15 diagnostisena markkerina immuunivasteen vapauttajilla annetun hoidon hoitovasteen ennustamiseksi | |
| CN102884433A (zh) | 用于检测抗体的方法 | |
| ES2555864T3 (es) | Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico | |
| CN104736561A (zh) | 帕潘立酮的抗体及其用途 | |
| US20190120833A1 (en) | Piezoelectric Plate Sensor and Uses Thereof | |
| CN108700581A (zh) | 用于定量生物试样中的测定对象物质的试剂盒及定量生物试样中的测定对象物质的方法 | |
| US20100015643A1 (en) | Method of quantitative determination of antigen protein and quantitative determination kit therefor | |
| JP2024167177A (ja) | ヌクレオシド逆転写酵素インヒビター治療に準拠したモニタリングのための製品および方法 | |
| CN111308085B (zh) | 一种超敏心肌肌钙蛋白i检测方法和试剂盒 | |
| CN109870581B (zh) | 一种定量检测HBsAg的试剂盒及方法 | |
| CN103823058A (zh) | 血清中抗原类蛋白的化学发光蛋白芯片方法和试剂盒 | |
| JP2017120263A (ja) | 腫瘍由来の微小胞マーカーによる薬物感受性予測方法 | |
| JPWO2009084369A1 (ja) | Ｈｉｖ−１抗原の検出用試薬及び検出方法 | |
| Liao et al. | Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody | |
| AU617334B2 (en) | Cea immunoassay free of human anti-mouse antibody false positives | |
| CN111316100B (zh) | 检测急性博尔纳病病毒(bdv)感染的方法及其诊断试剂盒，特别是组合区分急性及慢性和潜伏性bdv感染的方法及其诊断试剂盒 | |
| RU2701730C2 (ru) | Способ прогнозирования риска развития рака или диагностирования рака у индивидуума | |
| Detrez et al. | Characterization and application of a unique panel of monoclonal antibodies generated against etanercept | |
| CN113196057A (zh) | 病毒性肝癌的检测方法 | |
| US20240133877A1 (en) | Products and methods for monitoring adherence to nucleoside reverse transcriptase inhibitor therapy |